InvestSMART

CSL Limited (ASX: CSL) - Announcements

Current share price for CSL : $198.480 2.68 (1.33%)+

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$95,247 Appendix 2A 12 Feb 2021 11:34AM $277.270 $198.480 fallen by 28.42%
$95,247 Final Director's Interest Notice 1 Feb 2021 11:28AM $271.900 $198.480 fallen by 27%
$95,247 Resignation of Director 27 Jan 2021 8:29AM $275.540 $198.480 fallen by 27.97%
$95,247 Change of Director's Interest Notice 4 Jan 2021 2:06PM $285.130 $198.480 fallen by 30.39%
$95,247 Update on UQ-CSL v451 COVID-19 Vaccine 11 Dec 2020 7:31AM $301.290 $198.480 fallen by 34.12%
$95,247 New Vaccine Manufacturing Facility 16 Nov 2020 9:19AM $309.460 $198.480 fallen by 35.86%
$95,247 Appendix 2A 11 Nov 2020 9:44AM $304.600 $198.480 fallen by 34.84%
$95,247 CSLs Annual R&D Investor Briefing 2020 20 Oct 2020 8:35AM $304.130 $198.480 fallen by 34.74%
$95,247 Notice of Research & Development Investor Briefing 19 Oct 2020 8:21AM $299.000 $198.480 fallen by 33.62%
$95,247 Appendix 3G 16 Oct 2020 1:30PM $300.080 $198.480 fallen by 33.86%
$95,247 Change of Director's Interest Notice 16 Oct 2020 1:30PM $300.080 $198.480 fallen by 33.86%
$95,247 Final Director's Interest Notice 16 Oct 2020 1:30PM $300.080 $198.480 fallen by 33.86%
$95,247 Appendix 2A 14 Oct 2020 2:41PM $305.100 $198.480 fallen by 34.95%
$95,247 CSL 2020 AGM Poll Results 14 Oct 2020 1:51PM $305.620 $198.480 fallen by 35.06%
$95,247 Chairman's Address to Shareholders 14 Oct 2020 9:32AM $298.230 $198.480 fallen by 33.45%
$95,247 Appendix 2A 8 Oct 2020 10:04AM $294.160 $198.480 fallen by 32.53%
$95,247 CSL Supply Agreement for UQ Vaccine with Commonwealth 8 Oct 2020 9:21AM $291.860 $198.480 fallen by 31.99%
$95,247 Joy Linton named as Chief Financial Officer 1 Oct 2020 4:01PM $287.880 $198.480 fallen by 31.05%
$95,247 Appendix 2A 29 Sep 2020 12:27PM $295.770 $198.480 fallen by 32.89%
$95,247 Appendix 2A 23 Sep 2020 12:00PM $293.690 $198.480 fallen by 32.42%
$95,247 Change of Director's Interest Notice 23 Sep 2020 11:59AM $292.770 $198.480 fallen by 32.21%
$95,247 Update - Dividend/Distribution - CSL 14 Sep 2020 4:33PM $283.140 $198.480 fallen by 29.90%
$95,247 Appendix 2A 11 Sep 2020 3:40PM $284.030 $198.480 fallen by 30.12%
$95,247 Appendix 3G 11 Sep 2020 3:38PM $284.030 $198.480 fallen by 30.12%
$95,247 Change of Director's Interest Notice 11 Sep 2020 3:38PM $284.030 $198.480 fallen by 30.12%

526 - 550 of 1199 results

Page 22 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.